drugset / Trial / NCT05733468

TheraCal LC Coronal Pulpotomy and MTA Coronal Pulpotomy in Mature Permanent Molars

NCT05733468

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate and compare the clinical and radiographic success rate of TheraCal LC and MTA for coronal pulpotomy of mature permanent molar in 9-14 year children.

Timeline

Start
2022-07-01
Primary completion
2024-03-01
Completion
2024-05-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator MTA Unknown
Subject Theracal LC Other / unclassified

Indications